Impact of Hyperlipidemia on Plasma Protein Binding and Hepatic Drug Transporter and Metabolic Enzyme Regulation in a Rat Model of Gestational Diabetes

被引:20
作者
Anger, Gregory J. [1 ]
Piquette-Miller, Micheline [1 ]
机构
[1] Univ Toronto, Fac Pharm, Dept Pharmaceut Sci, Toronto, ON, Canada
基金
加拿大健康研究院;
关键词
SQUALENE SYNTHASE INHIBITOR; ALPHA-1-ACID GLYCOPROTEIN; PREGNANT-WOMEN; SERUM-ALBUMIN; MELLITUS; TRANSCRIPTION; EXPRESSION; GLYBURIDE; INSULIN; LIPIDS;
D O I
10.1124/jpet.110.165639
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
It is currently unknown whether gestational diabetes mellitus (GDM), a prevalent obstetrical complication, compounds the changes in drug disposition that occur naturally in pregnancy. Hyperlipidemia occurs in GDM. Using a rat model of GDM, we determined whether excess lipids compete with drugs for plasma protein binding. Because lipids activate nuclear receptors that regulate drug transporters and metabolic enzymes, we used proteome analysis to determine whether hyperlipidemia indirectly leads to the dysregulation of these proteins in the liver. GDM was induced on gestational day 6 (GD6) via streptozotocin injection. Controls received either vehicle alone or streptozotocin with subsequent insulin treatment. Liver and plasma were collected on GD20. Glyburide and saquinavir protein binding was determined by ultrafiltration, and an established solvent method was used for plasma delipidation. Proteomics analysis was performed by using isobaric tags for relative and absolute quantitation methodology with membrane-enriched hepatic protein samples. Relative to controls, GDM rat plasma contained more cholesterol and triglycerides. Plasma protein binding of glyburide and saquinavir was decreased in GDM. Delipidation normalized protein binding in GDM plasma. Proteins linked to lipid metabolism were strongly affected in the GDM proteomics data set, with prohyperlipidemic and antihyperlipidemic changes observed, and formed networks that implicated several nuclear receptors. Up-regulation of drug transporters and metabolic enzymes was observed (e. g., multidrug resistance 1/2, CYP2A1, CYP2B9, and CYP2D3). In this study, GDM-induced hyperlipidemia decreased protein binding and was associated with drug transporter and metabolic enzyme up-regulation in the liver. Both of these findings could change drug disposition in affected pregnancies, compounding changes associated with pregnancy itself.
引用
收藏
页码:21 / 32
页数:12
相关论文
共 40 条
[31]  
Piper E, 2006, CIRCULATION, V114, P288
[32]   ABNORMAL SERUM-PROTEIN BINDING OF ACIDIC DRUGS IN DIABETES-MELLITUS [J].
RUIZCABELLO, F ;
ERILL, S .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1984, 36 (05) :691-695
[33]   CYTOCHROME-P450IIE1 IS ELEVATED IN LYMPHOCYTES FROM POORLY CONTROLLED INSULIN-DEPENDENT DIABETICS [J].
SONG, BJ ;
VEECH, RL ;
SAENGER, P .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1990, 71 (04) :1036-1040
[34]   INFLUENCE OF FREE FATTY-ACID CONCENTRATION ON DRUG BINDING TO PLASMA ALBUMIN [J].
SPECTOR, AA ;
SANTOS, EC ;
ASHBROOK, JD ;
FLETCHER, JE .
ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1973, 226 (NOV26) :247-258
[35]   Benefit of farnesoid X receptor inhibition in obstructive cholestasis [J].
Stedman, Catherine ;
Liddle, Christopher ;
Coulter, Sally ;
Sonoda, Junichiro ;
Alvarez, Jacqueline G. ;
Evans, Ronald M. ;
Downes, Michael .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2006, 103 (30) :11323-11328
[36]   PLASMA-PROTEIN BINDING OF CATECHOLAMINES, PRAZOSIN AND PROPRANOLOL IN DIABETES-MELLITUS [J].
TROVIK, TS ;
JAEGER, R ;
JORDE, R ;
INGEBRETSEN, O ;
SAGER, G .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1992, 43 (03) :265-268
[37]   Measurements of maternal protein binding of bupivacaine throughout pregnancy [J].
Tsen, LC ;
Tarshis, J ;
Denson, DD ;
Osathanondh, R ;
Datta, S ;
Bader, AM .
ANESTHESIA AND ANALGESIA, 1999, 89 (04) :965-968
[38]   REGULATION OF LOW-DENSITY-LIPOPROTEIN-RECEPTOR MESSENGER-RNA BY INSULIN IN HUMAN HEPATOMA HEP G2 CELLS [J].
WADE, DP ;
KNIGHT, BL ;
SOUTAR, AK .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1989, 181 (03) :727-731
[39]   Streptozotocin- and alloxan-induced diabetes modifies total plasma and lipoprotein lipid concentration and composition without altering cholesteryl ester transfer activity [J].
Wasan, KM ;
Ng, SP ;
Wong, W ;
Rodrigues, BB .
PHARMACOLOGY & TOXICOLOGY, 1998, 83 (04) :169-175
[40]   DRUG-PROTEIN BINDING-KINETICS IN PATIENTS WITH TYPE-I DIABETES [J].
WORNER, W ;
PREISSNER, A ;
RIETBROCK, N .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1992, 43 (01) :97-100